The topic was stopped after scoping, this means the topic will not proceed to a Technology Appraisal
- Status:
- Topic selection
- Technology type:
- Medicine
- Decision:
- Not selected
- Reason for decision:
- Not eligible for Health Technology Evaluation guidance
- ID number:
- 3758
Project Team
- Project lead
- Michelle Adhemar
Email enquiries
If you have any queries please email [email protected]
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 01 December 2020 | Topic selection. . |
| 30 November 2020 | Following the written consultation on the draft remit and scope and discussions at the scoping workshop, NICE compiled a summary of its findings into a report that was discussed at the Topic Selection Oversight Panel (TSOP) in November 2020. The report included advice and recommendations to aid the decision-making process. TSOP concluded that an appraisal of remimazolam for sedation for people having diagnostic or therapeutic procedures was not appropriate. This means the technology in this indication will not be appraised by NICE. |
| 05 October 2020 (10:00) | Scoping workshop |
| 18 August 2020 - 16 September 2020 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators |
For further information on how we select topics for development, please see our page about prioritising our guidance topics